Our group identified an anti-apoptotic protein, BIRC3 (baculoviral IAP repeat containing 3), as a biomarker for MES GBM and a mediator of hypoxia-driven survival adaptation through HIF1α signaling [151] (Figure 3). This evidence concerns the gene BIRC3 and glioblastoma.